|
Volumn 17, Issue 3, 2006, Pages 140-145
|
Analysis of a medical aid administrator database for costs and utilisation of benefits by patients claiming for lipid-lowering agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACIPIMOX;
ADCO SIMVASTATIN;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BEZAFIBRATE;
COLESTYRAMINE;
FENOFIBRATE;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRAVA;
PRAVASTATIN;
ROLAB BEZAFIBRATE;
SIMVACOR;
SIMVASTATIN;
ADULT;
AGED;
COMORBIDITY;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
COST BENEFIT ANALYSIS;
DATA BASE;
DEMOGRAPHY;
DRUG COST;
DRUG USE;
ETHNIC GROUP;
FEMALE;
HEART MUSCLE ISCHEMIA;
HOSPITAL ADMINISTRATOR;
HOSPITAL COST;
HOSPITALIZATION;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
INCIDENCE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSISTANT;
METABOLIC DISORDER;
REVIEW;
ADOLESCENT;
ADULT;
AGED;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
CHILD;
COMORBIDITY;
DATABASES, FACTUAL;
DRUG COSTS;
DRUG UTILIZATION;
FEMALE;
HEALTH SERVICES RESEARCH;
HOSPITAL COSTS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPOLIPIDEMIC AGENTS;
INSURANCE CLAIM REVIEW;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PHYSICIAN'S PRACTICE PATTERNS;
SOUTH AFRICA;
|
EID: 33747708826
PISSN: 10159657
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (4)
|